Contents
Volume 75 Issue 10 | ARD October 2016
The Eular Journal
Editorial
1741 Predicting improvement in diffuse scleroderma: lessons
learnt
1806 Comparison of lipid and lipid-associated cardiovascular
risk marker changes after treatment with tocilizumab
OPEN ACCESS or adalimumab in patients with rheumatoid arthritis
C Gabay, I B McInnes, A Kavanaugh, K Tuckwell,
M Klearman, J Pulley, N Sattar
J E Pope
Clinical and epidemiological research
1743 Prediction of improvement in skin fibrosis in diffuse
cutaneous systemic sclerosis: a EUSTAR analysis
OPEN ACCESS
Editor
Tore K Kvien
Associate Editors
Francis Berenbaum
Johannes Bijlsma
Dimitrios Boumpas
Gerd Burmester
Mary Crow
Iain McInnes
David Pisetsky
Editorial office
Annals of the Rheumatic Diseases
BMJ Publishing Group Ltd
BMA House
Tavistock Square
London WCIH 9JR,UK
T: +44 (0)20 7383 6250
F: +44 (0)20 7383 6668
E: ard@bmj.com
Twitter: @ARD_BMJ
ISSN: 0003-4967 (print)
ISSN: 1468-2060 (online)
Impact Factor: 12.384
Disclaimer: ARD is owned and published by
BMJ Publishing Group Ltd (a wholly owned
subsidiary of the British Medical Association)
and the European League Against Rheumatism. The
owners grant editorial freedom tothe Editor of ARD.
ARD follows guidelines on editorial independence
produced by the World Association of Medical Editors
and the code on good publication practice ofthe
Committee on Publication Ethics.
ARD is intended for medical professionals and is
provided without warranty, express or implied.
Statements in the journal are the responsibility
of their authors and advertisers and not authors’
institutions the BMJ Publishing Group, the
European League Against Rheumatism or the
BMA unless otherwise specified or determined
by law. Acceptance of advertising does not imply
endorsement.
To the fullest extent permitted by law, the BMJ
Publishing Group shall not be liable for any loss, injury
or damage resulting from the use of ARD or any
information in it whether based on contract, tort, or
otherwise. Readers are advised to verify any
information they choose to rely on.
Copyright: © 2016 BMJ Publishing Group and
European League Against Rheumatism. All rights
reserved; no part of this publication may be reproduced
stored in a retrieval system, or transmitted in any form
or by any means, electronic, mechanical, photocopying
recording, or otherwise without prior permission
ARD is published by BMJ Publishing Group Ltd typeset
by Nova Techset Private Limited, Bengaluru & Chennai,
India and printed in the UK on acid-free paper.
Annals of the Rheumatic Diseases (ISSN No:
0003-4967) is published monthly by BMJ Publishing
Group and distributed in the USA by Air Business Ltd.
Periodicals postage paid at Jamaica NY 11431
POSTMASTER: send address changes to Annals of the
Rheumatic Diseases, Air Business Ltd, c/o Worldnet
Shipping Inc., 156-15, 146th Avenue, 2nd Floor,
Jamaica, NY 11434, USA.
R Dobrota, B Maurer, N Graf, S Jordan, C Mihai,
O Kowal-Bielecka, Y Allanore, O Distler, on behalf
of EUSTAR coauthors
1749 Painful knee but not hand osteoarthritis is an
independent predictor of mortality over 23 years
follow-up of a population-based cohort of middle-aged
women
S Kluzek, M T Sanchez-Santos, K M Leyland, A Judge,
T D Spector, D Hart, C Cooper, J Newton, N K Arden
1757 Increased pretreatment serum IFN-β/α ratio predicts
non-response to tumour necrosis factor α inhibition
in rheumatoid arthritis
T W Muskardin, P Vashisht, J M Dorschner,
M A Jensen, B S Chrabot, M Kern, J R Curtis, M I Danila,
S S Cofield, N Shadick, P A Nigrovic, E W St Clair,
C O Bingham III, R Furie, W Robinson, M Genovese,
C C Striebich, J R O’Dell, G M Thiele, L W Moreland,
M Levesque, S L Bridges Jr, P K Gregersen, T B Niewold
1813 Comparative effects of biologics on cardiovascular risk
among older patients with rheumatoid arthritis
J Zhang, F Xie, H Yun, L Chen, P Muntner, E B Levitan,
M M Safford, S T Kent, M T Osterman, J D Lewis, K Saag,
J A Singh, J R Curtis
1819 Prevalence of ultrasound synovial inflammatory findings
in healthy subjects
I Padovano, F Costantino, M Breban, M A D’Agostino
1824 Clinical factors, anticitrullinated peptide antibodies and
MRI-detected subclinical inflammation in relation to
progression from clinically suspect arthralgia to arthritis
H W van Steenbergen, L Mangnus, M Reijnierse,
T W J Huizinga, A H M van der Helm-van Mil
1831 Parental rheumatoid arthritis and long-term child
morbidity: a nationwide cohort study
A L Rom, C S Wu, J Olsen, D Jawaheer, M L Hetland,
B Ottesen, L S Mørch
1838 Pregnancy outcomes in patients with ankylosing
spondylitis: a nationwide register study
G L Jakobsson, O Stephansson, J Askling, L T H Jacobsson
1763 Value of ultrasonography as a marker of early response
to abatacept in patients with rheumatoid arthritis and
OPEN ACCESS an inadequate response to methotrexate: results from
the APPRAISE study
M-A D’Agostino, R J Wakefield, H Berner-Hammer,
O Vittecoq, G Filippou, P Balint, I Möller, A Iagnocco,
E Naredo, M Østergaard, M Boers, C Gaillez, K V Holder,
M Le Bars, on behalf of the OMERACT-EULAR-Ultrasound
Task Force
1770 Elucidating the burden of recurrent and chronic digital
ulcers in systemic sclerosis: long-term results from the
OPEN ACCESS DUO Registry
M Matucci-Cerinic, T Krieg, L Guillevin, B Schwierin,
D Rosenberg, P Cornelisse, C P Denton
1843 Real-world comparative risks of herpes virus infections
in tofacitinib and biologic-treated patients with
rheumatoid arthritis
J R Curtis, F Xie, H Yun, S Bernatsky, K L Winthrop
1848 Increased arterial wall inflammation in patients with
ankylosing spondylitis is reduced by statin therapy
F M van der Valk, S J B Moens, S L Verweij,
A C Strang, A J Nederveen, H J Verberne, M T Nurmohamed,
D L Baeten, E S G Stroes
1852 Osteoarthritic bone marrow lesions almost exclusively
colocate with denuded cartilage: a 3D study using data
from the Osteoarthritis Initiative
M A Bowes, S WD McLure, C BH Wolstenholme,
G R Vincent, S Williams, A Grainger, P G Conaghan
1777 Sofosbuvir plus ribavirin for hepatitis C virus-associated
cryoglobulinaemia vasculitis: VASCUVALDIC study
D Saadoun, V Thibault, S N Si Ahmed, L Alric, M Mallet,
C Guillaud, H Izzedine, A Plaisier, H Fontaine, M Costopoulos,
M Le Garff-Tavernier, C Hezode, S Pol, L Musset, T Poynard,
P Cacoub
1783 Signal intensity alteration in the infrapatellar fat pad
at baseline for the prediction of knee symptoms and
structure in older adults: a cohort study
MORE CONTENTS 䉴
This article has been chosen by the Editor to be of special interest
or importance and is freely available online.
W Han, D Aitken, Z Zhu, A Halliday, X Wang, B Antony,
F Cicuttini, G Jones, C Ding
1789 How comparable are rates of malignancies in
patients with rheumatoid arthritis across the world?
A comparison of cancer rates, and means to optimise
their comparability, in five RA registries
J Askling, N Berglind, S Franzen, T Frisell, C Garwood,
J D Greenberg, M Ho, M Holmqvist, L Horne, E Inoue,
K Michaud, F Nyberg, D A Pappas, G Reed, E Tanaka,
T N Tran, S M M Verstappen, H Yamanaka,
E Wesby-van Swaay, D Symmons
OPEN ACCESS
This article has been made freely available online under the BMJ
Journals Open Access scheme.
See http://ard.bmj.com/site/about/guidelines.xhtml#open
This journal is a member of and subscribes to the principles of the
Committee on Publication Ethics
http://publicationethics.org/
1797 Can rheumatoid arthritis (RA) registries provide
contextual safety data for modern RA clinical trials?
The case for mortality and cardiovascular disease
K Michaud, N Berglind, S Franzén, T Frisell, C Garwood,
J D Greenberg, M Ho, M Holmqvist, L Horne, E Inoue,
F Nyberg, D A Pappas, G Reed, D Symmons, E Tanaka,
T N Tran, S M M Verstappen, E Wesby-van Swaay,
H Yamanaka, J Askling
The online version of this article contains multiple choice questions
hosted on BMJ Learning.
Contents
Basic and translational research
1858 Nucleosome in patients with systemic sclerosis:
possible association with immunological abnormalities
via abnormal activation of T and B cells
A Yoshizaki, T Taniguchi, R Saigusa, T Fukasawa, S Ebata,
H Numajiri, K Nakamura, T Yamashita, T Takahashi,
T Toyama, Y Asano, T F Tedder, S Sato
1866 Single cell cloning and recombinant monoclonal
antibodies generation from RA synovial B cells reveal
OPEN ACCESS frequent targeting of citrullinated histones of NETs
Volume 75 Issue 10 | ARD October 2016
e64
M Scheinberg, V Azevedo
e65
A Schwenzer, X Jiang, T R Mikuls, J B Payne, H R Sayles,
A-M Quirke, B M Kessler, R Fischer, P J Venables,
K Lundberg, K S Midwood
e66
e67
e68
e69
e70
e63
Response to: ‘Infliximab and CT-P13 immunogenicity
assessment in PLANETAS and PLANETRA main
and extension studies: utility of laboratory methods
description’ by Francesca Meacci et al
J Braun
Response to: ‘Let’s stop fooling ourselves. In RA, only
ACR/EULAR criteria define remission and equate with
absence of disease!’ by Boers
P Emery, C O Bingham III, G R Burmester, V P Bykerk,
D E Furst, X Mariette, D van der Heijde, R van Vollenhoven,
C Arendt, I Mountian, O Purcaru, D Tatla, B VanLunen,
M E Weinblatt
Electronic pages
Correspondence
F Meacci, M Manfredi, M Infantino, V Grossi, M Benucci
Let’s stop fooling ourselves. In RA, only ACR/EULAR
criteria define remission and equate with absence
of disease!
M Boers
J van Heemst, A H Hensvold, X Jiang, H van Steenbergen,
L Klareskog, T W J Huizinga, A van der Helm-van Mil,
A I Catrina, R E M Toes, K Lundberg, D van der Woude
Infliximab and CT-P13 immunogenicity assessment
in PLANETAS and PLANETRAS main and extension
studies: utility of laboratory methods description
Response to: ‘The role of infrapatellar fat pad
resection in total knee arthroplasty’ by White et al
W Han, F Pan, Z Liu, Z Zhu, X Wang, S Zheng, B Antony,
C Ding
1891 Protective effect of HLA-DRB1*13 alleles during specific
phases in the development of ACPA-positive RA
e62
The role of infrapatellar fat pad resection in total knee
arthroplasty
L D White, T M Melhuish
1884 T cell subsets: an immunological biomarker to predict
progression to clinical arthritis in ACPA-positive
OPEN ACCESS individuals
L Hunt, E M Hensor, J Nam, A N Burska, R Parmar, P Emery,
F Ponchel
Difference between SB4 and reference etanercept
in the hepatobiliary disorders not considered to be
caused by SB4: response to letter by Scheinberg and
Azevedo
P Emery, J Vencovský, J Ghil, S Y Cheong, Y H Rho
E Corsiero, M Bombardieri, E Carlotti, F Pratesi, W Robinson,
P Migliorini, C Pitzalis
1876 Identification of an immunodominant peptide
from citrullinated tenascin-C as a major target for
OPEN ACCESS autoantibodies in rheumatoid arthritis
Difference between Enbrel and Benepali treatment
groups in ‘hepatobiliary disorders’
Denosumab, cortical bone and bone erosions
in rheumatoid arthritis
M Rossini, G Adami, O Viapiana, L Idolazzi, D Gatti
e71
Response to: ‘Denosumab, cortical bone and bone
erosion in rheumatoid arthritis’ by Rossini et al
T Takeuchi, Y Tanaka, N Ishiguro, H Yamanaka, T Yoneda,
T Ohira, N Okubo, H K Genant, D van der Heijde